Source: Business Wire

Press Release: Verastem : Verastem Oncology Announces Andrei Shustov, M.D., Recipient of 2nd Annual Innovation in Care Award

BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq: VSTM), (Verastem Oncology or the Company), a biopharmaceutical company focused on developing and commercializing medicines seeking to improve the survival and quality of life of cancer patients, today announced that Andrei Shustov, M.D., Professor of Medicine and Hematology, University of Washington, Associate Member, Clinical Research Division, Fred Hutchinson Cancer Research Center and President and Founder of the T-Cell Leukemia and Lymphoma F

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Annual Revenue
Brian Stuglik's photo - CEO of Verastem


Brian Stuglik

CEO Approval Rating


Verastem is a biopharmaceutical company that researches, develops and commercializes novel therapeutics for the treatment of cancer. Read more